| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.487 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 6.542 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.308 | 935 | 591 | 451 | 443 | 341 | 334 | 313 | 289 | 287 |
| Gross Profit/Loss - EUR | 5.234 | -935 | -591 | -451 | -443 | -341 | -334 | -313 | -289 | -287 |
| Net Profit/Loss - EUR | 5.039 | -935 | -591 | -451 | -443 | -341 | -334 | -313 | -289 | -287 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bros Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.197 | 1.332 | 1.384 | 1.408 | 1.428 | 1.448 | 1.462 | 1.444 | 1.439 | 1.431 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.152 | 1.287 | 1.340 | 1.365 | 1.386 | 1.407 | 1.422 | 1.403 | 1.399 | 1.391 |
| Cash | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Shareholders Funds | 645 | -297 | -883 | -1.318 | -1.735 | -2.044 | -2.332 | -2.652 | -2.932 | -3.203 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.463 | 2.330 | 2.760 | 3.016 | 3.259 | 3.492 | 3.794 | 4.096 | 4.372 | 4.634 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4612 - 4612" | |||||||||
| CAEN Financial Year |
4612
|
|||||||||
Comments - Bros Bio Srl